Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae

Antimicrob Agents Chemother. 2001 Jun;45(6):1911-4. doi: 10.1128/AAC.45.6.1911-1914.2001.

Abstract

To determine if susceptibility testing of Streptococcus pneumoniae could detect those isolates that had one of the recognized mechanisms of fluoroquinolone resistance, 101 isolates were selected; the levofloxacin MIC for 28 of these isolates was > or =4 microg/ml. Only isolates with both parC and gyrA mutations or with no recognized resistance mechanisms were reliably identified by using these results. Isolates with only a parC mutation could not be detected reliably using any susceptibility testing method.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • DNA Gyrase
  • DNA Topoisomerase IV
  • DNA Topoisomerases, Type II
  • Drug Resistance, Microbial
  • Fluoroquinolones
  • Microbial Sensitivity Tests
  • Mutation
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • DNA Topoisomerase IV
  • DNA Gyrase
  • DNA Topoisomerases, Type II